First-Trimester Maternal Plasma Concentrations of C-Reactive Protein in Low-Risk Patients and the Subsequent Development of Chorioamnionitis

ABSTRACT

Baseline elevations of C-reactive protein (CRP) during pregnancy have been associated with adverse outcomes, including preterm delivery. Acute elevations have also been associated with intrauterine infections. The relationship between chronic, baseline elevations of CRP and histological chorioamnionitis, however, has not previously been explored. A nested case-control study was performed within a prospective observational cohort of low-risk patients seeking prenatal care. CRP was measured from maternal plasma collected before 13 weeks of estimated gestational age. Cases were defined by histological chorioamnionitis, and controls were selected randomly from patients without chorioamnionitis. We identified 36 cases of chorioamnionitis. There were no significant differences (p = 0.64) in CRP concentrations between cases and controls. CRP concentrations remained nonsignificant in a logistic regression model that incorporated prepregnancy body mass index, placental weight, race, and gestational age at delivery (p = 0.72). We concluded that the development of histological chorioamnionitis is not associated with elevations in maternal plasma CRP earlier in pregnancy.

KEYWORDS

C-reactive protein - chorioamnionitis - placental pathology

REFERENCES

• 1 Ridker P M, Hennekens C H, Buring J E, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.  N Engl J Med. 2000;  342 836-843
• 2 Sacks G P, Seyani L, Lavery S, Trew G. Maternal C-reactive protein levels are raised at 4 weeks gestation.  Hum Reprod. 2004;  19 1025-1030
• 3 Majello B, Arcone R, Toniatti C, Ciliberto G. Constitutive and IL-6-induced nuclear factors that interact with the human C-reactive protein promoter.  EMBO J. 1990;  9 457-465
• 4 Gould J M, Weiser J N. Expression of C-reactive protein in the human respiratory tract.  Infect Immun. 2001;  69 1747-1754
• 5 Jabs W J, Lögering B A, Gerke P et al.. The kidney as a second site of human C-reactive protein formation in vivo.  Eur J Immunol. 2003;  33 152-161
• 6 Malek A, Bersinger N A, Di Santo S, Mueller M D, Sager R, Schneider H. C-reactive protein production in term human placental tissue.  Placenta. 2006;  27 619-625
• 7 Yoon B H, Romero R, Shim J Y, Shim S S, Kim C J, Jun J K. C-reactive protein in umbilical cord blood: a simple and widely available clinical method to assess the risk of amniotic fluid infection and funisitis.  J Matern Fetal Neonatal Med. 2003;  14 85-90
• 8 Shim S S, Romero R, Jun J K, Moon K C, Kim G, Yoon B H. C-reactive protein concentration in vaginal fluid as a marker for intra-amniotic inflammation/infection in preterm premature rupture of membranes.  J Matern Fetal Neonatal Med. 2005;  18 417-422
• 9 Raio L, Ghezzi F, Mueller M D, McDougall J, Malek A. Evidence of fetal C-reactive protein urinary excretion in early gestation.  Obstet Gynecol. 2003;  101 1062-1063
• 10 Trochez-Martinez R D, Smith P, Lamont R F. Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review.  BJOG. 2007;  114 796-801
• 11 Salafia C M, Sherer D M, Spong C Y et al.. Fetal but not maternal serum cytokine levels correlate with histologic acute placental inflammation.  Am J Perinatol. 1997;  14 419-422
• 12 Qiu C, Sorensen T K, Luthy D A, Williams M A. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus.  Paediatr Perinat Epidemiol. 2004;  18 377-384
• 13 Tjoa M L, van Vugt J M, Go A T, Blankenstein M A, Oudejans C B, van Wijk I J. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction.  J Reprod Immunol. 2003;  59 29-37
• 14 Pitiphat W, Gillman M W, Joshipura K J et al.. Plasma C-reactive protein in early pregnancy and preterm delivery.  Am J Epidemiol. 2005;  162 1108-1113
• 15 Lohsoonthorn V, Qui C, Williams M A. Maternal serum C-reactive protein concentrations in early pregnancy and subsequent risk of preterm delivery.  Clin Biochem. 2007;  40 330-335
• 16 Redline R W, Faye-Petersen O, Heller D et al.. Amniotic infection syndrome: nosology and reproducibility of placental reaction patters.  Pediatr Dev Pathol. 2003;  6 435-448
• 17 Redline R W, Heller D, Keating S, Kingdom J. Placental diagnostic criteria and clinical correlation—a workshop report.  Placenta. 2005;  26 Suppl A S114-117
• 18 Nath C A, Ananth C V, Smulian J C et al.. Histologic evidence of inflammation and risk of placental abruption.  Am J Obstet Gynecol. 2007;  197(3) 319.e1-6
• 19 Williams M C, O'Brien W F, Nelson R N, Spellacy W N. Histologic chorioamnionitis is associated with fetal growth restriction in term and preterm infants.  Am J Obstet Gynecol. 2000;  183 1094-1099
• 20 Woldesenbet M, Perlman J M. Histologic chorioamnionitis: an occult marker of severe pulmonary hypertension in the term newborn.  J Perinatol. 2005;  25 189-192
• 21 Wu Y W, Colford J M. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis.  JAMA. 2000;  284 1417-1424
• 22 Ghezzi F, Franchi M, Raio L et al.. Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery.  Am J Obstet Gynecol. 2002;  186 268-273
• 23 Goldenberg R L, Iams J D, Mercer B M et al.. The Preterm Prediction Study: toward a multiple-marker test for spontaneous preterm birth.  Am J Obstet Gynecol. 2001;  185 643-651
• 24 Steel J H, O' Donoghue K, Kennea N L, Sullivan M H, Edwards A D. Maternal origin of inflammatory leukocytes in preterm fetal membranes, shown by fluorescence in situ hybridisation.  Placenta. 2005;  26 672-677

0 Presented at the Society of Maternal-Fetal Medicine annual meeting, Dallas, Texas, January 31, 2008.